Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival. (Q44993391)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Adnan Alseidi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2

Flavio G Rocha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

9

Scott Helton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Thomas Biehl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ravi Moonka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

John A Ryan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Bruce Lin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Vincent Picozzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1530-1537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Redefining the R1 resection in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Pancreatic cancer surgery in the new millennium: better prediction of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Classic Whipple versus pylorus-preserving pancreaticoduodenectomy in the ACS NSQIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Trends in hospital volume and operative mortality for high-risk surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Risk of morbidity and mortality following hepato-pancreato-biliary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

Most Pancreatic Cancer Resections are R1 Resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3486-Z

10.1245/S10434-014-3486-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 March 2020

1042191517

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24473642%20AND%20SRC:MED&resulttype=core&format=json